|
(4E,7E,10E,13E,16E,19E)-docosahexaenoylcarnitine |
|
CHEBI:134424 |
|
(4E,7E,10E,13E,16E,19E)-docosahexaenoylcarnitine |
|
An O-acylcarnitine in which the acyl group is specified as (4E,7E,10E,13E,16E,19E)-docosahexaenoyl. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C29H47NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-29(33)34-27(25-28(31)32)26-30(2,3)4/h6-7,10-11,13-14,17-18,21-22,27H,5,8-9,12,15-16,19-20,23-26H2,1-4H3/b7-6+,11-10+,14-13+,18-17+,22-21+ |
AOSDFVDGMYPTHD-NQXOOMTHSA-N |
C(\CC/C=C/C\C=C\CC\C=C\CC/C=C/CCC(=O)OC(CC([O-])=O)C[N+](C)(C)C)=C/CC |
|
rat metabolite
Any mammalian metabolite produced during a metabolic reaction in rat (Rattus norvegicus).
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
|
|
View more via ChEBI Ontology
Outgoing
|
(4E,7E,10E,13E,16E,19E)-docosahexaenoylcarnitine
(CHEBI:134424)
has role
mouse metabolite
(CHEBI:75771)
(4E,7E,10E,13E,16E,19E)-docosahexaenoylcarnitine
(CHEBI:134424)
has role
rat metabolite
(CHEBI:86264)
(4E,7E,10E,13E,16E,19E)-docosahexaenoylcarnitine
(CHEBI:134424)
is a
O-acylcarnitine
(CHEBI:17387)
|
|
3-{[(4E,7E,10E,13E,16E,19E)-docosa-4,8,12,15,19-pentaenoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
|